OpenBilldrug price receipt

NADAC week of 2026-10-14

VIGAMOX 0.5% EYE DROPS

FDA nonproprietary name: moxifloxacin hydrochloride

For 3 mL

Pharmacies pay

$95.42 filed

3 × $31.808 per ML

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-06-17 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$182.11 filed

3 × $60.70401 per ML, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

1.9× estimated

Medicare paid 1.9× what pharmacies pay.

Part D averages every strength and form sold under “Vigamox” / “Moxifloxacin HCl” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-06-17 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$114.73 estimated

$95.42 + $14.31 (15%) + $5.00 fee per fill = $114.73

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-06-17 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

VIGAMOX 0.5% EYE DROPS is how the CMS NADAC file names this product. The FDA NDC Directory lists it as moxifloxacin hydrochloride, under the trade name “VIGAMOX”.

FDA gives its dosage form as solution/ drops and its route as ophthalmic.

The labeler, the company named on the label, is Harrow Eye, LLC.

FDA’s Established Pharmacologic Class for it is Fluoroquinolone Antibacterial.

The NADAC file of 2026-10-14 prices it under 2 NDCs (National Drug Codes); the FDA directory lists 1 of them.

NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $95.42 for 3 mL (3 × $31.808 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-06-17. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 4, carried forward from the previous file; 5, calculated based on package size.

The NADAC of all 2 NDCs was carried forward from an earlier file (NADAC explanation code 2 or 4), not newly surveyed: those prices took effect on 2026-06-17. The file is new; the price is not.

NADAC also lists, on the row of its brand NDCs, what pharmacies pay for the generic equivalent, a different product: $1.59631 per ML filed.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

All 2 NDCs

Other strengths, forms and brands

2 other products in the NADAC file share the FDA nonproprietary name moxifloxacin hydrochloride with VIGAMOX 0.5% EYE DROPS.

ProductPharmacies pay per unitMedicare per unit
MOXIFLOXACIN 0.5% EYE DROPS
generic · solution/ drops / solution
$1.59631 per ML filed
eff. 2026-09-23
We don’t know yet
MOXIFLOXACIN HCL 400 MG TABLET
generic · tablet, film coated
$1.33723 per EA filed
eff. 2026-09-23
$3.92378 per EA filed
Part D 2024 average
VIGAMOX 0.5% EYE DROPS this page
brand · solution/ drops
$31.808 per ML filed
eff. 2026-06-17
$60.70401 per ML filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-06-17, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 2 NDCs’ NADAC prices is $31.808 per ML filed.

Of the 5 other products in FDA’s Fluoroquinolone Antibacterial class priced per ML, 1 has a higher middle NADAC price and 4 a lower one. The one in the middle is CIPROFLOX-DEXAMETH OTIC SUSP, at $7.12383 per ML filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-06-17, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $182.11 for 3 mL, at an average of $60.70401 per ML in 2024 (2024-01-01 to 2024-12-31) for “Vigamox” and “Moxifloxacin HCl”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 489 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for VIGAMOX 0.5% EYE DROPS labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Vigamox / Moxifloxacin HCl: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's ML. Joined on brand name.
Why does this page start at 3 mL?
NADAC prices this product per ML. The FDA NDC Directory’s package description gives 3 mL in one package for the 1 of this product’s 2 NDCs it lists (“1 BOTTLE in 1 CARTON (82667-700-03) / 3 mL in 1 BOTTLE”), so the card starts at one package: 3 ML. Change it to match your prescription.